Scholz Simone L, Möller Inga, Reis Henning, Süßkind Daniela, van de Nes Johannes A P, Leonardelli Sonia, Schilling Bastian, Livingstone Elisabeth, Schimming Tobias, Paschen Annette, Sucker Antje, Murali Rajmohan, Steuhl Klaus-Peter, Schadendorf Dirk, Westekemper Henrike, Griewank Klaus G
Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3464-3470. doi: 10.1167/iovs.17-21838.
The most common malignant intraocular tumors with a high mortality in adults are uveal melanomas. Uveal melanomas arise most frequently in the choroid or ciliary body (97%) and rarely in the iris (3%). Whereas conjunctival and posterior uveal (ciliary body and choroidal) melanomas have been studied in more detail genetically, little data exist regarding iris melanomas.
In our study, we genetically analyzed 19 iris melanomas, 8 ciliary body melanomas, 3 ring melanomas, and 4 iris nevi. A targeted next-generation sequencing approach was applied, covering the mutational hotspot regions of nine genes known to be mutated in conjunctival and uveal melanoma (BRAF, NRAS, KIT, GNAQ, GNA11, CYSLTR2, SF3B1, EIF1AX, and BAP1).
Activating GNAQ or GNA11 hotspot mutations were detected in a mutually exclusive fashion in 84% (16/19) of iris melanomas. EIF1AX gene mutations also were frequent, detected in 42% (8/19) of iris melanomas. In 4 iris nevi, one GNAQ mutation was identified. GNAQ, GNA11, EIF1AX, and BAP1 mutations were identified at varying frequencies in ciliary body and ring melanomas.
In this most comprehensive genetic analysis of iris melanomas published to date, we find iris melanomas to be related genetically to choroidal and ciliary body melanomas, frequently harboring GNAQ, GNA11, and EIF1AX mutations. Future studies will need to assess if screening mutation profiles in iris melanomas may be of diagnostic or prognostic value.
葡萄膜黑色素瘤是成人中最常见且死亡率高的恶性眼内肿瘤。葡萄膜黑色素瘤最常发生于脉络膜或睫状体(97%),很少发生于虹膜(3%)。虽然结膜和后葡萄膜(睫状体和脉络膜)黑色素瘤在遗传学方面已有更详细的研究,但关于虹膜黑色素瘤的数据却很少。
在我们的研究中,我们对19例虹膜黑色素瘤、8例睫状体黑色素瘤、3例环状黑色素瘤和4例虹膜痣进行了基因分析。采用靶向二代测序方法,覆盖已知在结膜和葡萄膜黑色素瘤中发生突变的9个基因的突变热点区域(BRAF、NRAS、KIT、GNAQ、GNA11、CYSLTR2、SF3B1、EIF1AX和BAP1)。
在84%(16/19)的虹膜黑色素瘤中以互斥方式检测到GNAQ或GNA11热点激活突变。EIF1AX基因突变也很常见,在42%(8/19)的虹膜黑色素瘤中被检测到。在4例虹膜痣中,鉴定出1个GNAQ突变。在睫状体和环状黑色素瘤中以不同频率鉴定出GNAQ、GNA11、EIF1AX和BAP1突变。
在迄今为止发表的关于虹膜黑色素瘤的最全面基因分析中,我们发现虹膜黑色素瘤在遗传学上与脉络膜和睫状体黑色素瘤相关,经常携带GNAQ、GNA11和EIF1AX突变。未来的研究需要评估虹膜黑色素瘤的筛查突变谱是否具有诊断或预后价值。